Analyst Research Report Snapshot

Title:

PLETHORA SOLUTIONS HOLDINGS - WOMEN'S HEALTH PROGRESS

Price:

$10.00

Provider:

Edison Investment Research

Date:

01 Oct 2007

Pages:

8

Type:

AcrobatPDF

Companies referenced:

PLE.L

Available for Immediate Download
Summary:

Recent positive Phase II results for the interstitial cystitis project PSD597 have provided further validation of Plethora’s low-risk business model. Phase II data are additionally expected for R&D projects in urinary incontinence and other indications, and should increase the profile of the non-sexual health arena that has hitherto received little attention. If successful this will give Plethora three women’s health products ready for licensing out. FOR MORE INFORMATION ON ATTACHED RESEARCH PLEASE CALL 020 7190 1755 OR EMAIL RESEARCH@EDISONINVESTMENTRESEARCH.CO.UK OR VISIT WWW.EDISONINVESTMENTRESEARCH.CO.UK

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.